Trial Profile
TNK for Loculated Pleural Effusions in Patients With Malignancy
Status:
Discontinued
Phase of Trial:
Phase II/III
Latest Information Update: 08 Jan 2015
Price :
$35
*
At a glance
- Drugs Tenecteplase (Primary)
- Indications Embolism and thrombosis; Fibrosis; Pleural effusion
- Focus Adverse reactions; Therapeutic Use
- 30 Apr 2012 New trial record